Transition-metal-catalyzed uninterrupted four-step sequence to access trisubstituted isoxazoles

Organic Letters

Volumn 13, Issue 24, 2011, Pages 6418-6421

  Gayon, Eric ^a   Quinonero, Ophélie ^a   Lemouzy, Sébastien ^a   Vrancken, Emmanuel ^a   Campagne, Jean Marc ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84055214045     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol202719n     Document Type: Article

References (39)

1. For a recent highlight on this topic, see: Vaxelaire, C.; Winter, P.; Christmann, M. Angew. Chem., Int. Ed. 2011, 50, 2.
2. Clarke, P. A.; Santos, S.; Martin, W. H. C. Green Chem. 2007, 9, 438.
3. (a) Ishikawa, H.; Suzuki, T.; Hayashi, Y. Angew. Chem., Int. Ed. 2009, 48, 1304.
4. (b) Ishikawa, H.; Suzuki, T.; Orita, H.; Uchimaru, T.; Hayashi, Y. Chem.; Eur. J. 2010, 16, 12616.
5. (c) Ishikawa, H.; Honma, M.; Hayashi, Y. Angew. Chem., Int. Ed. 2011, 50, 2824.
6. (a) Sperry, J.; Wright, B. Curr. Opin. Drug Discovery Dev. 2008, 8, 723.
7. (b) Giomi, D.; Cordero, F.; Machetti, F. In Comprehensive Heterocyclic Chemistry III; Katriski, A. R., Ramsden, C. A., Scriven, E. F. V., Taylor, R. J. K., Joule, J., Eds.; Elsevier: Oxford, U.K., 2008; Vol. 4, p 365.
8. (c) Sutharchanadevi, M. In Comprehensive Heterocyclic Chemistry II; Katriski, A. R., Rees, A. R., Scriven, E. F. V., Shinkai, I., Eds.; Elsevier: Oxford, U.K., 1996; Vol. 3, p 221.
9. (a) Waldo, J. P.; Larock, R. C. Org. Lett. 2005, 7, 5203.
10. (b) Waldo, J. P.; Larock, R. C. J. Org. Chem. 2007, 72, 9643.
11. (c) Crossley, J. A.; Browne, D. L. J. Org. Chem. 2010, 75, 5414.
12. (d) Waldo, J. P.; Metha, S.; Neuenswander, B.; Lushington, G. H.; Larock, R. C. J. Comb. Chem. 2008, 10, 658.
13. (e) Okitsu, T.; Potewar, T. M.; Wada, A. J. Org. Chem. 2011, 76, 3438.
14. Denmark, S. E.; Kallemeyn, J. M. J. Org. Chem. 2005, 70, 2839.
15. (a) Davies, M. W.; Wybrow, R. A. J.; Johnson, C. N.; Harrity, J. P. A. Chem. Commun. 2001, 1558.
16. (b) Kumar, J. S. D.; Ho, M. M.; Leung, J. M.; Toyokuni, T. Adv. Synth. Catal. 2002, 344, 1146.
17. (c) Moore, J. E.; Davies, M. W.; Goodenough, K. M.; Wybrow, R. A. J.; York, M.; Johnson, C. N.; Harrity, J. P. A. Tetrahedron 2005, 61, 6707.
18. For selected examples of isoxazole synthesis by other methods, see: (a) Talley, J. J.; Brown, D. L.; Carter, J. S.; Graneto, M. J.; Koboldt, C. M.; Masferrer, J. L.; Perkins, W. E.; Rogers, R. S.; Shaffer, A. F.; Zhang, Y. Y.; Zweifel, B. S.; Seibert, K. J. Med. Chem. 2000, 43, 775.
19. (b) Di Nunno, L.; Vitale, P.; Scilimati, A.; Tacconelli, S.; Patrignani, P. J. Med. Chem. 2004, 47, 4881.
20. (c) Ueda, M.; Sato, A.; Ikeda, Y.; Miyoshi, T.; Naito, T.; Miyata, O. Org. Lett. 2010, 12, 2594.
21. (d) Burhard, J. A.; Tchitchanov, B. H.; Carreira, E. M. Angew. Chem., Int. Ed. 2011, 50, 5379.
22. (e) Jackowski, O.; Lecourt, T.; Micouin, L. Org. Lett. 2011, 13, 5664.
23. (a) Debleds, O.; dal Zotto, C.; Vrancken, E.; Campagne, J. M. Adv. Synth.Catal. 2009, 351, 1991.
24. 1(b)Gayon, E.; Debleds, O.;Nicouleau, M.; Lamaty, F.; Vand der Lee, A.; Vrancken, E.; Campagne, J. M. J. Org. Chem. 2010, 75, 6050.
25. (c) Debleds, O.; Gayon, E.; Ostaszuk, E.; Vrancken, E.; Campagne, J. M. Chem.; Eur. J. 2010, 16, 12207.
26. (d) Debleds, O.; Gayon, E.; Vrancken, E.; Campagne, J. M. Beilstein J. Org. Chem. 2011, 7, 866.
27. 2a is easily obtained in good isolated yield (91%) by refluxing 1a and CbzNHOH in the presence of FeCl3 (10 mol %) inDCMaccording to the Zhan et al procedure: Zhan, Z.-P.; Yu, J.-L.; Liu, H.-J.; Cui, Y.-Y.; Yang, R.-F.; Yang, W.-Z.; Li, J.-P J. Org. Chem. 2006, 71, 8298-8301.
28. Arcadi, A.; Cacchi, S.; Del Rosario, M.; Fabrizi, G.; Marinelli, F. J. Org. Chem. 1996, 61, 9280.
29. Hu, Y.; Nawoschik, K. J.; Liao, Y.; Ma, J.; Fathi, R.; Yang, Z. J. Org. Chem. 2004, 69, 2235.
30. For an application of this strategy to the synthesis of indolizinone, see: Kim, I.; Kim, K. Org. Lett. 2010, 12, 2500.
31. The obtention of analogues of 7a through the N-O bond cleavage of isoxazolines has already been described: (a) Lopez-Callen, E.; Keller, M.; Eberbach, W. Eur. J. Org. Chem. 2003, 1438.
32. (b) Lager, M.; Dietrich, D.; Weinrich, D.; Rück-Braun, K. Heterocycles 2007, 74, 743. To the best of our knowledge, the direct transformation of propargylic hydroxylamines to enones is unknown.
33. (a) Moreau, X.; Campagne, J.-M. J. Organomet. Chem. 2003, 687, 322.
34. (b) Moreau, X.; Campagne, J.-M.; Meyer, G.; Jutand, A. Eur. J. Org. Chem. 2005, 3749.
35. (c) Tong, Z.; Gao, P.; Deng, H.; Zhang, L.; Xu, P.; Zhai, H. Synlett 2008, 3239.
36. (a) Pd(II) complexes are generally used for the activation of ? systems; see: Cacchi, S.; Arcadi, A. In Handbook of Organopalladium Chemistry for Organic Synthesis; Negishi, E. I., Ed.; Wiley-Interscience: New York, 2002; Vol. 2, p 2193.
37. (b) For a rare study on the possible use of Pd(0) in this type of reaction, see: Ahlquist, M.; Fabrizi, G.; Cacchi, S.; Norrby, P.-O. Chem. Commun. 2005, 4196-4198.
38. For a paper dealing with the association of Pd and Fe in a catalytic process, see: Terrasson, V.; Michaux, J.; Gaucher, A.; Wehbe, J.; Marque, S.; Prim, D.; Campagne, J.-M. Eur. J. Org. Chem. 2007, 5332.
39. Alternative solvents (AcOEt, MeNO2, DMF.) for the whole sequence, that is, able to promote the substitution/cyclization and the hydrogenolysis steps, were also examined but did not lead to any satisfactory results.